Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Has results
×
Neoplasms
×
mirvetuximab soravtansine
×
Clear all
Filters
3
NCT05041257
2026-01-09
PICCOLO
AbbVie
Phase 2
Completed
79 enrolled
14 charts
NCT01609556
2021-02-17
IMGN853-0401
ImmunoGen, Inc.
Phase 1
Completed
206 enrolled
46 charts